Prospective Study of BK Virus Infection in Patients with Inflammatory Bowel Disease

Patients with inflammatory bowel disease (IBD) have an immune-deficient baseline status further modulated by immunosuppressive therapy that may promote the reactivation of latent viruses such as BK virus (BKV). The aim of this prospective study was to determine the prevalence of BKV infection in IBD...

Full description

Saved in:
Bibliographic Details
Main Authors: Virginia Flores, Belén Rodríguez-Sánchez, Ignacio Marín-Jiménez, Emilio Bouza, Luis Menchén, Patricia Muñoz
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1155/2014/970528
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558315999068160
author Virginia Flores
Belén Rodríguez-Sánchez
Ignacio Marín-Jiménez
Emilio Bouza
Luis Menchén
Patricia Muñoz
author_facet Virginia Flores
Belén Rodríguez-Sánchez
Ignacio Marín-Jiménez
Emilio Bouza
Luis Menchén
Patricia Muñoz
author_sort Virginia Flores
collection DOAJ
description Patients with inflammatory bowel disease (IBD) have an immune-deficient baseline status further modulated by immunosuppressive therapy that may promote the reactivation of latent viruses such as BK virus (BKV). The aim of this prospective study was to determine the prevalence of BKV infection in IBD patients and its potential relationship with the immunosuppressive treatment. Paired urine and plasma samples from 53 consecutive patients with IBD and 53 controls were analyzed. BKV detection was performed by conventional PCR and positive samples were further quantified by real-time PCR. No viremia was detected. BKV viruria was significantly more common in IBD patients than among the controls (54.7% versus 11.3%; P<0.0001). The only risk factor for BKV viruria in IBD was age (47.2±16.3 versus 37.8±15.2; P=0.036), and there was a trend towards higher rate of viruria in outpatients (61.5% versus 38.5%; P=0.096) and in those not receiving ciprofloxacin (59.5% versus 40.5%; P=0.17). A clear impact of the immunosuppressive regimen on BKV infection could not be demonstrated.
format Article
id doaj-art-522b3f5f44f44b2d8f6fd60fd4df1cc0
institution Kabale University
issn 2356-6140
1537-744X
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-522b3f5f44f44b2d8f6fd60fd4df1cc02025-02-03T01:32:44ZengWileyThe Scientific World Journal2356-61401537-744X2014-01-01201410.1155/2014/970528970528Prospective Study of BK Virus Infection in Patients with Inflammatory Bowel DiseaseVirginia Flores0Belén Rodríguez-Sánchez1Ignacio Marín-Jiménez2Emilio Bouza3Luis Menchén4Patricia Muñoz5Department of Digestive Diseases, General University Hospital Gregorio Marañón, Dr. Esquerdo 46, 28007 Madrid, SpainDepartment of Clinical Microbiology and Infectious Diseases, General University Hospital Gregorio Marañón, Dr. Esquerdo 46, 28007 Madrid, SpainDepartment of Digestive Diseases, General University Hospital Gregorio Marañón, Dr. Esquerdo 46, 28007 Madrid, SpainDepartment of Clinical Microbiology and Infectious Diseases, General University Hospital Gregorio Marañón, Dr. Esquerdo 46, 28007 Madrid, SpainDepartment of Digestive Diseases, General University Hospital Gregorio Marañón, Dr. Esquerdo 46, 28007 Madrid, SpainDepartment of Clinical Microbiology and Infectious Diseases, General University Hospital Gregorio Marañón, Dr. Esquerdo 46, 28007 Madrid, SpainPatients with inflammatory bowel disease (IBD) have an immune-deficient baseline status further modulated by immunosuppressive therapy that may promote the reactivation of latent viruses such as BK virus (BKV). The aim of this prospective study was to determine the prevalence of BKV infection in IBD patients and its potential relationship with the immunosuppressive treatment. Paired urine and plasma samples from 53 consecutive patients with IBD and 53 controls were analyzed. BKV detection was performed by conventional PCR and positive samples were further quantified by real-time PCR. No viremia was detected. BKV viruria was significantly more common in IBD patients than among the controls (54.7% versus 11.3%; P<0.0001). The only risk factor for BKV viruria in IBD was age (47.2±16.3 versus 37.8±15.2; P=0.036), and there was a trend towards higher rate of viruria in outpatients (61.5% versus 38.5%; P=0.096) and in those not receiving ciprofloxacin (59.5% versus 40.5%; P=0.17). A clear impact of the immunosuppressive regimen on BKV infection could not be demonstrated.http://dx.doi.org/10.1155/2014/970528
spellingShingle Virginia Flores
Belén Rodríguez-Sánchez
Ignacio Marín-Jiménez
Emilio Bouza
Luis Menchén
Patricia Muñoz
Prospective Study of BK Virus Infection in Patients with Inflammatory Bowel Disease
The Scientific World Journal
title Prospective Study of BK Virus Infection in Patients with Inflammatory Bowel Disease
title_full Prospective Study of BK Virus Infection in Patients with Inflammatory Bowel Disease
title_fullStr Prospective Study of BK Virus Infection in Patients with Inflammatory Bowel Disease
title_full_unstemmed Prospective Study of BK Virus Infection in Patients with Inflammatory Bowel Disease
title_short Prospective Study of BK Virus Infection in Patients with Inflammatory Bowel Disease
title_sort prospective study of bk virus infection in patients with inflammatory bowel disease
url http://dx.doi.org/10.1155/2014/970528
work_keys_str_mv AT virginiaflores prospectivestudyofbkvirusinfectioninpatientswithinflammatoryboweldisease
AT belenrodriguezsanchez prospectivestudyofbkvirusinfectioninpatientswithinflammatoryboweldisease
AT ignaciomarinjimenez prospectivestudyofbkvirusinfectioninpatientswithinflammatoryboweldisease
AT emiliobouza prospectivestudyofbkvirusinfectioninpatientswithinflammatoryboweldisease
AT luismenchen prospectivestudyofbkvirusinfectioninpatientswithinflammatoryboweldisease
AT patriciamunoz prospectivestudyofbkvirusinfectioninpatientswithinflammatoryboweldisease